RP-HPLC study on pharmacokinetics of xyloketal B in New Zealand rabbits

张娓,杨宏图,项琪,李宗奕,黄亚东,庞冀燕,许忠良,林永成

DOI: https://doi.org/10.16155/j.0254-1793.2012.08.009

2012-01-01

Abstract:Objective:To develop a reverse phase HPLC method for the determination of xyloketal B in rabbit plasma and its pharmacokinetics study.Methods:Plasma samples were extracted by liquid-liquid extraction with ethyl acetate.For quantification,compound 1 was chosen as an internal standard.The separation was performed on a Phenomenex C18 column with an isocratic mobile phase of methanol-acetonitrile-water(30∶ 30∶ 40) at a flow rate of 0.8 mL·min-1.The eluent was monitored at 220nm.Results:The method showed a good speicificity between analytes and matrix.A good linearity was observed over the concentration range of 0.4-50 μg·mL-1 with correlation coefficients of 0.9995.The limits of detection(LOD) was 0.2 μg·mL-1.The mean recovery of xyloketal B in QC samples at concentration of 0.8,10 and 40 μg·mL-1 were between 85.2%~105.5%,intra-and inter-day precision RSDs were all less than 10%(n=5).Conclusions:The analysis method of xyloketal B in rabbit plasma was established for the first time,which lay a methodological foundation for the biopharmaceutical analysis of xyloketal B.The developed method was specific,accurate and sensitive.The results indicated that the analytic method was satisfactorily applied to perform preclinical pharmacokinetic study of xyloketal B in rabbit plasma.The plasma concentration-time curve fitted the two-compartment model after intravenous administration in rabbits.